Dr Rossela Roberts

Darlithydd

  1. Cyhoeddwyd

    Carer administration of as-needed sub-cutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT

    Poolman, M., Roberts, J., Wright, S., Hendry, A., Goulden, N., Holmes, E., Byrne, A., Perkins, P., Hoare, Z., Nelson, A., Hiscock, J., Hughes, D., O'Connor, J., Foster, B., Reymond, L., Healy, S., Lewis, P., Wee, B., Johnstone, R. P., Roberts, R., Parkinson, A., Roberts, S. & Wilkinson, C., 2 Meh 2020, Yn: Health Technology Assessment. 24, 25, 150 t.

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  2. Cyhoeddwyd

    A quantitative analysis of antipsychotic prescribing trends for the treatment of schizophrenia in England and Wales

    Roberts, R., Neasham, A., Lambrinudi, C. & Khan, A., 18 Ebr 2018, Yn: Journal of the Royal Society of Medicine. 9, 4

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  3. Cyhoeddwyd

    A thematic analysis assessing clinical decision-making in antipsychotic prescribing for schizophrenia

    Roberts, R., Neasham, A., Lambrinudi, C. & Khan, A., 10 Medi 2018, Yn: BMC Psychiatry. 18, 290.

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid